How to Compare Research Peptide Suppliers

Why This Matters Now

The research peptide market has matured enough that most suppliers have learned to display the right vocabulary — HPLC purity, COA, third-party tested — without necessarily doing what those terms imply. For researchers who depend on compound integrity for reproducible results, the gap between a supplier's claims and their actual methodology can mean degraded data, failed experiments, or methods sections that cannot be replicated.

This guide exists because the right questions are rarely obvious until you've made a mistake. It is designed to give researchers a concrete evaluation framework: the specific things to verify, the specific red flags to recognize, and the specific standards that distinguish accountability from marketing language.

The Three Testing Methods — and What Each Actually Tells You

A credible peptide COA requires at minimum three distinct tests. Most suppliers include one or two. Understanding what each test reveals — and what it cannot reveal — is the foundation of any meaningful supplier comparison.

HPLC — Purity Assessment

High-performance liquid chromatography separates the components of a sample and measures the percentage represented by the target compound. A result of ≥99% HPLC purity means 99% or more of the sample mass is the target peptide. The remaining fraction could be synthesis byproducts, residual solvents, or minor impurities.

What HPLC cannot tell you: whether the compound is actually the peptide you ordered. HPLC measures purity, not identity. A sample that is 99% pure could be 99% of the wrong compound entirely.

LC-MS — Identity Confirmation

Liquid chromatography-mass spectrometry separates the compound (LC) and measures its molecular mass (MS). The spectrum confirms molecular identity by matching the detected mass against the theoretical mass for the target peptide. LC-MS is the only routine test that can confirm you have the right compound.

A supplier providing only HPLC results — without LC-MS — cannot confirm that what you received is what was labeled. This is not a hypothetical risk. Read the detailed breakdown of HPLC vs. LC-MS methodology.

Endotoxin / LAL Assay — Safety for Cell Work

The Limulus amebocyte lysate (LAL) assay measures bacterial endotoxin contamination in EU/mg (endotoxin units per milligram). For researchers using peptides in cell-based assays, endotoxins produce immune activation artifacts that confound results. A compound can be 99% pure and still be unusable in cell culture if endotoxin levels are elevated.

The general threshold for in vitro cell work is <1 EU/mg. A COA without an endotoxin result is incomplete for any application involving living cells. Full endotoxin testing reference guide.

Batch Testing vs. Vial Testing: A Critical Distinction

Even when all three tests are performed, there is a second critical variable: what was tested — a sample from the production batch, or your specific vial.

Batch testing means a representative sample from a production lot is tested. Your individual vial is not tested directly. This is the standard for most commodity peptide suppliers. It is legitimate quality control, but it has limits: degradation during packaging, cross-contamination from fill equipment, or variation within a lot are not detected at the vial level.

Vial-level testing means each individual unit is tested. This adds cost and time but eliminates the gap between batch-level QC and the actual compound in your hands.

When evaluating a supplier, ask specifically: "Is the COA generated from testing my vial or a batch sample?" The answer tells you a great deal about their quality infrastructure. Full comparison of batch vs. vial testing methodology.

Batch Traceability: Your Methods Section Depends on It

Research reproducibility requires that the exact compound used in a study be documentable: the specific lot, the purity at time of use, the testing methodology, and the supplier. Without batch traceability, a researcher cannot accurately write a materials section, and another lab cannot source an equivalent compound to replicate the work.

A credible supplier assigns a unique batch or lot number to every production run, associates that lot number with a specific COA, and makes that COA publicly accessible by lot number. If a supplier cannot provide lot-level COA retrieval, batch traceability is not supported — regardless of claims. Full guide to batch traceability standards.

The Evaluation Framework: What to Ask Any Supplier

Red Flags: What Legitimate Suppliers Do Not Do

• Display a purity percentage without a supporting chromatogram or underlying test data
• Claim "third-party tested" without naming the laboratory or providing the COA document
• Provide a COA without an endotoxin result for compounds used in research
• Make COA access contingent on account creation or a completed purchase
• Lack batch or lot numbers on product labels or in shipment documentation
• Describe products in therapeutic or clinical terms rather than research compound terms
• Offer unusually low prices on complex peptides without a verifiable quality explanation
• Post generic or undated COA documents not linked to specific batch IDs

Our Standards at Lone Star Peptide Co.

Lone Star Peptide Co. was built in Houston specifically to address the transparency gap in the research peptide supply chain. Every compound we ship meets the following standards — documented, verifiable, and publicly accessible.

These standards are verifiable — not asserted. Every COA is on our library page. Every batch ID traces to a specific test result from a named external laboratory. If you are evaluating us alongside other suppliers, apply the same framework to everyone, including us.

Frequently Asked Questions